Cargando…
Challenge of immune-mediated adverse reactions in the emergency department
Multiple drugs of a new class of cancer treatments called immune checkpoint inhibitors, which work by enabling the immune system to attack tumour cells, have been approved for a variety of indications in recent years. Immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 and programmed death-...
Autores principales: | Daniels, Gregory A, Guerrera, Angela D, Katz, Donna, Viets-Upchurch, Jayne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582806/ https://www.ncbi.nlm.nih.gov/pubmed/31113799 http://dx.doi.org/10.1136/emermed-2018-208206 |
Ejemplares similares
-
Advance care planning: challenges at the emergency department of a cancer care center
por: Cruz-Carreras, Maria T., et al.
Publicado: (2017) -
Diagnosis and management of immune‐related adverse effects of immune checkpoint therapy in the emergency department
por: Yeung, Sai‐Ching Jim, et al.
Publicado: (2020) -
Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018) -
COVID-19 vaccine adverse reactions bring patients to emergency departments
por: Fertel, Baruch S., et al.
Publicado: (2022) -
Evaluation and management of acute high-grade immunotherapy-related neurotoxicity
por: Sandoval, Marcelo, et al.
Publicado: (2023)